PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy

NCT05980715 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

324

Enrollment

OTHER

Sponsor class

Conditions

HNSCC
Radiotherapy
PD-1

Interventions

DRUG: PD-1inhibitor
RADIATION: concurrent chemoradiotherapy

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]